Key statistics
On Tuesday, BioMarin Pharmaceutical Inc (BMRN:NSQ) closed at 56.67, 7.07% above its 52-week low of 52.93, set on Apr 09, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 58.60 |
---|---|
High | 58.67 |
Low | 56.52 |
Bid | 56.66 |
Offer | 56.68 |
Previous close | 58.23 |
Average volume | 2.16m |
---|---|
Shares outstanding | 191.78m |
Free float | 188.90m |
P/E (TTM) | 21.61 |
Market cap | 11.17bn USD |
EPS (TTM) | 2.69 USD |
Data delayed at least 15 minutes, as of Jul 15 2025 20:55 BST.
More ▼
- BioMarin Announces Completion of Acquisition of Inozyme
- BioMarin Presents Five-Year Phase 3 Results Reinforcing Long-Term Efficacy and Safety of ROCTAVIAN® (valoctocogene roxaparvovec-rvox) at International Society on Thrombosis and Haemostasis 2025 Congress
- BioMarin Strengthens Enzyme Therapy Business with Acquisition of Inozyme Pharma
- BioMarin Presents New Data for VOXZOGO® (vosoritide) in Children with Achondroplasia and Other Skeletal Conditions at Two International Endocrinology Meetings
- BioMarin Reports First Quarter 2025 Results and Reaffirms Full-year Guidance
- BioMarin to Host First Quarter 2025 Financial Results Conference Call and Webcast on Thursday, May 1, 2025, at 4:30pm ET
More ▼